Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer

Journal of Thoracic Oncology

Volumn 4, Issue 4, 2009, Pages 499-504

  Slatore, Christopher G ^a,b   Au, David H ^a,b   Hollingworth, William ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cost effectiveness; Non small cell lung cancer; QALY; Smoking cessation program

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; VARENICLINE;

ARTICLE; CANCER SURGERY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HUMAN; LUNG CANCER; LUNG LOBECTOMY; LUNG RESECTION; NICOTINE REPLACEMENT THERAPY; PERIOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; SMOKING CESSATION PROGRAM; SURGICAL MORTALITY; COST BENEFIT ANALYSIS; ECONOMICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MORTALITY; PROBABILITY; SMOKING CESSATION;

CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; HUMANS; LUNG NEOPLASMS; MARKOV CHAINS; QUALITY-ADJUSTED LIFE YEARS; SMOKING CESSATION;

EID: 67649387273     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318195e23a     Document Type: Article

References (40)

1. Ries LAG MD, Krapcho M, Mariotto A, et al. (Eds.). SEER Cancer Statistics Review, 1975-2004, based on November 2006 SEER data submission, posted to the SEER web site, 2007. Available at: http://seer.cancer.gov/csr/1975-2004/. Bethesda, MD: National Cancer Institute, 2007.
2. Anonymous. The health consequences of smoking: a report of the surgeon general. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 2004. CDC Publication No. 7829. Available at: www.cdc.gov/tobacco/sgr/sgr-2004/index.htm.
3. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323-329. (Pubitemid 30496873)
4. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-239. (Pubitemid 40216240)
5. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA 2005;294:1505-1510. (Pubitemid 41362687)
6. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Costeffectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997;278:1759-1766. (Pubitemid 27510076)
7. Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest 1996;110:1199-1202. (Pubitemid 26380473)
8. Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 2004;126: 1733-1741. (Pubitemid 39643973)
9. Sardari Nia P, Weyler J, Colpaert C, Vermeulen P, Van Marck E, Van Schil P. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005;47:351-359. (Pubitemid 40248739)
10. Bize R, Burnand B, Mueller Y, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2005:CD004705.
11. Wolfenden L, Wiggers J, Knight J, et al. A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial. Anaesthesia 2005;60:172-179. (Pubitemid 40220686)
12. Sorensen LT, Jorgensen T. Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial. Colorectal Dis 2003;5:347-352. (Pubitemid 36833824)
13. Ratner PA, Johnson JL, Richardson CG, et al. Efficacy of a smokingcessation intervention for elective-surgical patients. Res Nurs Health 2004;27:148-161.
14. Moller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002;359:114-117. (Pubitemid 34112539)
15. Moller A, Villebro N. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2005:CD002294.
16. Schnoll RA, Zhang B, Rue M, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 2003;21:355-365. (Pubitemid 46606166)
17. Sanderson Cox L, Patten CA, Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol 2002;20:3461-3469.
18. Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132:161S-177S. (Pubitemid 47502806)
19. Croghan IT, Schroeder DR, Hays JT, et al. Nicotine dependence treatment: perceived health status improvement with 1-year continuous smoking abstinence. Eur J Public Health 2005;15:251-255.
20. Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006;106:17-27. (Pubitemid 43032545)
21. Zhang Z, Xu F, Wang S, Li N, Wang C. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer. Lung Cancer 2008;60:434-440. (Pubitemid 351726354)
22. Pohlig C. Smoking cessation counseling: a practice management perspective. Chest 2006;130:1231-1233. (Pubitemid 44583757)
23. Theobald M, Jaen CR. An update on tobacco cessation reimbursement. Fam Pract Manag 2006;13:75-76, 78.
24. Anonymous. Available at: www.drugstore.com. Accessed February 12, 2008.
25. Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006;15:352-358. (Pubitemid 44606729)
26. Barrera R, Shi W, Amar D, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005;127: 1977-1983. (Pubitemid 46260085)
27. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989;64:609-616. (Pubitemid 19197632)
28. Anonymous. Centers for Medicare & Medicaid Services Outlier Payments, 2007. Available at: http://www.cms.hhs.gov/AcuteInpatientPPS/04-outlier.asp. Accessed September 13, 2007.
29. Wang J, Olak J, Ultmann RE, Ferguson MK. Assessment of pulmonary complications after lung resection. Ann Thorac Surg 1999;67:1444-1447. (Pubitemid 29320253)
30. Anonymous. Centers for Medicare and Medicaid Services: DRG costs, 2008. Available at: http://www.cms.hhs.gov/MedicareFeeforSvcPartsAB/ Downloads/DRG05.pdf. Accessed March 13, 2008.
31. Manser RL, Wright G, Byrnes G, et al. Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer. Lung Cancer 2006;53:217-229. (Pubitemid 43994235)
32. Shaw JW, Coons SJ, Foster SA, Leischow SJ, Hays RD. Responsiveness of the Smoking Cessation Quality of Life (SCQoL) questionnaire. Clin Ther 2001;23:957-969. (Pubitemid 32554577)
33. Nichol MB, Sengupta N, Globe DR. Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med Decis Making 2001;21:105-112. (Pubitemid 32318761)
34. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146: 473-481.
35. Kent MS, Korn P, Port JL, Lee PC, Altorki NK, Korst RJ. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. Ann Thorac Surg 2005;80:1215-1222; discussion 1222-11213 (Pubitemid 41354092)
36. Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med 1998;13:716-717.
37. Fujisawa T, Iizasa T, Saitoh Y, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999;17:2086-2091. (Pubitemid 29318839)
38. Tan YK, Wee TC, Koh WP, Wang YT, Eng P, Tan WC, Seow A. Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status. Lung Cancer 2003; 40:237-246. (Pubitemid 36627703)
39. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004;125:27-37. (Pubitemid 38114560)
40. Zhou W, Heist RS, Liu G, et al. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer 2006;53:375-380. (Pubitemid 44189564)